The Platinum 30: A Curated Selection From AAII’s Model Portfolios
A few stocks grading highly on the criteria used in each of our eight model stock portfolios present a diversified sample.
Charles Rotblut
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
A few stocks grading highly on the criteria used in each of our eight model stock portfolios present a diversified sample.
Charles Rotblut
Omar Beirat
Eunice Kim
Grace Malone
Grace Malone
| Share Statistics | THC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $20,349.6 | $1,875.0 | 86% |
|
| Shares Out (Mil) | 87.6 | 77.1 | 60% |
|
| Institutional Ownership | 99.0% | 88.9% | 84% |
|
| Float (Mil) | 85.1 | 50.3 | 58% |
|
| Beta | 1.27 | 0.86 | 74% |
|
| Avg Daily Volume (000s) | 1,675 | 466 | 79% |
|
| Price Change (52-week) |
61.9% | 78.5% | 85% |
|
| Growth | THC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 3.9% | 10.9% | 31% |
|
| Net Income (5yr) | 28.7% | (1.1%) | 83% |
|
| EPS (5yr) | 32.8% | 3.0% | 83 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.7%) | (18.2%) | 47% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 17 | 18 | 20 | |
| Current EPS | $4.643 | $21.068 | $20.445 | |
| Month Ago EPS | $4.103 | $17.856 | $17.720 | |
| # Rev Up | 2 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | $4.135 | $17.629 | $17.710 | |
| Year/Year Chg | (42.0%) | 36.0% | 42.3% | |
| Financials | THC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $21,455 | $1,464 | 92% |
|
| Net Income (TTM) (Mil) | $1,703 | $15 | 91% |
|
| EPS (TTM) | $19.289 | $0.300 | 98% |
|
| Operating Cash Flow (TTM) (Mil) | $4,366 | $138 | 94% |
|
| Net Cash Flow (TTM) (Mil) | ($32) | $7 | 23% |
|
| Long-Term Debt (Q1) (Mil) | $13,128 | $323 | 93% |
|
| Enterprise Value (Q1) (Mil) | $30,689 | $2,130 | 88% |
|
| Valuation | THC | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.52 | 2.90 | 76% |
|
| P/E | 13.2 | 26.8 | 29% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.4 | 1.1 | 18% |
|
| Ratios | THC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 41.7% | 27.6% | 52% |
|
| Net Margin | 10.3% | 1.1% | 64% |
|
| ROA | 5.6% | 1.8% | 75% |
|
| ROE | 37.9% | 6.9% | 90% |
|
| Liabilities to Assets | 71.6% | 60.0% | 67% |
|
| F-Score | 8 | 5 | 94% |
|
Passing Stock Screens
As of 7/30/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 7.0% |
| +/- S&P 500: | -0.5 |
| Performance Since Inception: | 13.4% |
| +/- S&P 500: | +5.9 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors